Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay

Abstract The 2013 update of the American Society of Clinical Oncology-College of American Pathologists (ASCO-CAP) human epidermal growth factor receptor 2 (HER2) testing guidelines recommend using an alternative chromosome 17 probe assay to resolve HER2 results determined to be equivocal by immunohi...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Neelam V. Desai, Vanda Torous, Joel Parker, James T. Auman, Gary B. Rosson, Cassandra Cruz, Charles M. Perou, Stuart J. Schnitt, Nadine Tung
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2018-07-01
Serie:	Breast Cancer Research
Soggetti:	HER2-positive breast cancer PAM50 intrinsic subtype HER2 alternative probe ASCO-CAP guidelines
Accesso online:	http://link.springer.com/article/10.1186/s13058-018-1005-z
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!